4826 | It has been a while but I am back. | kaiser | 09/28/2025 5:45:13 PM |
4105 | IDVC 0039 | kaiser | 07/29/2014 9:36:45 AM |
4104 | MELY 0023 nice bitcoin mining news out. | kaiser | 07/29/2014 9:32:00 AM |
4103 | MELY 0026 nice hits coming in | kaiser | 07/16/2014 1:51:43 PM |
4102 | BAA .345 | kaiser | 07/16/2014 11:31:09 AM |
4101 | BAA .3393 | kaiser | 07/16/2014 11:26:59 AM |
4100 | BAA .331 | kaiser | 07/16/2014 11:12:34 AM |
4099 | IDNG 0033 X 0034 | kaiser | 07/16/2014 10:34:11 AM |
4098 | MELY 0026 | kaiser | 07/16/2014 10:32:21 AM |
4097 | IDVC 0035 X 0038 | kaiser | 07/16/2014 10:08:24 AM |
4096 | BAA .322 | kaiser | 07/16/2014 10:07:00 AM |
4095 | IDNG 003 X 0034 | kaiser | 07/16/2014 10:03:27 AM |
4094 | BAA .3198 | kaiser | 07/16/2014 10:02:51 AM |
4093 | IDVC 003 X 0039 | kaiser | 07/16/2014 10:02:24 AM |
4092 | BAA .319 | kaiser | 07/16/2014 9:58:23 AM |
4091 | BAA .3164 gold mining company. Should be a nice | kaiser | 07/16/2014 9:42:03 AM |
4090 | IDVC 003 X 0034 | kaiser | 07/16/2014 9:39:28 AM |
4089 | MELY 0025 company working on bitcoin mining | kaiser | 07/16/2014 9:38:16 AM |
4088 | BCAP 0006 X 0007 bid building. Company updates | kaiser | 07/16/2014 9:37:14 AM |
4087 | MELY 0021 | kaiser | 07/09/2014 11:03:39 AM |
4086 | BCAP 0008 | kaiser | 07/09/2014 10:49:48 AM |
4085 | BCAP 0006 X 0007 | kaiser | 07/09/2014 9:43:21 AM |
4084 | BCAP 0006 hitting and falling | kaiser | 07/09/2014 9:32:03 AM |
4083 | SHMX 0004 X 0005 | kaiser | 07/08/2014 9:43:29 AM |
4082 | SHMX 0004 hitting | kaiser | 07/07/2014 1:55:32 PM |
4081 | IDVC 005 | kaiser | 07/07/2014 1:46:02 PM |
4080 | IDVC 0045 | kaiser | 07/07/2014 1:28:18 PM |
4079 | IDVC 0038 | kaiser | 07/07/2014 1:19:46 PM |
4078 | BCAP 0006 nice hits coming in | kaiser | 07/07/2014 12:39:30 PM |
4077 | IDVC 0032 | kaiser | 07/07/2014 12:36:57 PM |
4076 | IDVC 0029 | kaiser | 07/07/2014 12:35:24 PM |
4075 | IDVC 0025 X 0027 | kaiser | 07/07/2014 12:25:50 PM |
4074 | IDVC 0025 nice 8-k out. | kaiser | 07/07/2014 12:24:03 PM |
4073 | BCAP 0005 X 0006 | kaiser | 07/07/2014 12:14:55 PM |
4072 | IDVC 0025 hitting | kaiser | 07/07/2014 12:13:25 PM |
4071 | MELY 002 X 0021 | kaiser | 07/07/2014 12:07:12 PM |
4070 | BCAP 0004 X 0005 | kaiser | 07/07/2014 11:58:31 AM |
4069 | AZFL 0029 should be a nice bounce play | kaiser | 07/07/2014 10:45:42 AM |
4068 | BCAP 0004 nice buys coming in. Company should | kaiser | 07/07/2014 9:35:09 AM |
4067 | DKAM 002 | kaiser | 07/02/2014 1:14:31 PM |
4066 | DKAM 0019 | kaiser | 07/02/2014 1:01:12 PM |
4065 | DKAM 0018 | kaiser | 07/02/2014 11:59:26 AM |
4064 | DKAM 0017 should be a nice bounce play | kaiser | 07/02/2014 10:26:13 AM |
4063 | IDNG 0037 nice news out. | kaiser | 07/02/2014 9:42:22 AM |
4062 | IDNG 0038 | kaiser | 07/02/2014 9:37:38 AM |
4061 | IDNG 0037 hitting | kaiser | 07/02/2014 9:34:47 AM |
4060 | IDVC 0025 nice acquisition news out today. | kaiser | 07/01/2014 10:07:02 PM |
4059 | BCAP 0004 annual reports filed. | kaiser | 07/01/2014 9:54:58 PM |
4058 | IDVC 002 acquisition news out. | kaiser | 07/01/2014 1:33:51 PM |
4057 | GMO 1.16 nice chart should move | kaiser | 07/01/2014 11:51:09 AM |
4056 | APRU 0005 nice buys coming in | kaiser | 06/27/2014 9:39:17 AM |
Recent Articles
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025